Showing results (61-70 of 113) with videos related to

Sort By:
Pageof 12
Zhonghua Wai Ke Za Zhi [Chinese Journal of Surgery]|August 14, 2015
[Analysis of biochemical recurrence following radical prostatectomy]Bo Dai, Kun Chang, Yunyi Kong, et al.
International Journal of Biological Sciences|December 12, 2024
SCGN recruits macrophages by regulating chemokine secretion in clear cell renal cell carcinomaTuanjie Guo, Xinchao Zhang, Xuan Wang, et al.
Cancer Letters|July 9, 2023
HKDC1 reprograms lipid metabolism to enhance gastric cancer metastasis and cisplatin resistance via forming a ribonucleoprotein complexPing Zhao, Fei Yuan, Lijuan Xu, et al.
Annals of Diagnostic Pathology|July 16, 2022
GATA3 aids in distinguishing fumarate hydratase-deficient renal cell carcinoma from papillary renal cell carcinomaYang Liu, Yihan Dong, Yijin Gu, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|April 9, 2026
POU2F3 in SCLC: Diagnostic Utility in Neuroendocrine Low/Negative SCLC and Discrimination From Other Thoracic Malignancies and Other Small Blue Round Cell TumorsXiaoyan Chen, Fangfang Zou, Haimin Xu, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|June 22, 2022
Tumor-infiltrating OX40+ lymphocytes is an independent positive prognostic factor for patients with pancreatic ductal adenocarcinomaQiwei Zhang, Weiwei Rui, Yongsheng Jiang, et al.
Discover Oncology|June 3, 2024
Dynamic changes of SCGN expression imply different phases of clear cell renal cell carcinoma progressionTuanjie Guo, Xuan Wang, Tao Wang, et al.
BMC Cancer|December 8, 2022
Transcription factor c-Jun modulates GLUT1 in glycolysis and breast cancer metastasisPing Zhu, Guoping Liu, Xue Wang, et al.
Carcinogenesis|July 3, 2021
tRNA-derived fragment tRFLys-CTT-010 promotes triple-negative breast cancer progression by regulating glucose metabolism via G6PCPing Zhu, Jingjing Lu, Xiuling Zhi, et al.
Frontiers in Immunology|July 29, 2021
Case Report: Successful Management of a Refractory Plasmablastic Lymphoma Patient With Tislelizumab and LenalidomideLili Cheng, Qi Song, Mengke Liu, et al.
Pageof 12